homonojirimycin has been researched along with ambroxol in 1 studies
*Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride. [MeSH]
*Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride. [MeSH]
Studies (homonojirimycin) | Trials (homonojirimycin) | Recent Studies (post-2010) (homonojirimycin) | Studies (ambroxol) | Trials (ambroxol) | Recent Studies (post-2010) (ambroxol) |
---|---|---|---|---|---|
15 | 0 | 7 | 714 | 130 | 225 |
Protein | Taxonomy | homonojirimycin (IC50) | ambroxol (IC50) |
---|---|---|---|
Lysosomal acid glucosylceramidase | Homo sapiens (human) | 4.1 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.5574 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.391 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benjamin, ER; Boyd, RE; Khanna, R; Lee, G; Rybczynski, P; Valenzano, KJ; Wustman, BA | 1 |
1 review(s) available for homonojirimycin and ambroxol
Article | Year |
---|---|
Pharmacological chaperones as therapeutics for lysosomal storage diseases.
Topics: Cell Line; Glycolipids; Humans; Lysosomal Storage Diseases; Molecular Chaperones; Structure-Activity Relationship | 2013 |